Apyx Medical (APYX) Accumulated Depreciation & Amortization (2011 - 2025)

Apyx Medical has reported Accumulated Depreciation & Amortization for 15 years, with the latest figure at $4.1 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 23.17% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $4.1 million (up 23.17% YoY), and the FY2025 full-year result was $4.1 million, up 23.17% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $4.1 million, up from $3.4 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $4.1 million in Q4 2025, with the low at $157000.0 in Q1 2024.
• Historically, Accumulated Depreciation & Amortization has averaged $891437.5 across 5 years, with a median of $506000.0 in 2022.
• Annual changes were most pronounced in 2023 — Accumulated Depreciation & Amortization dropped 25.0% — and 2024, when it soared 384.68%.
• Apyx Medical's Accumulated Depreciation & Amortization stood at $903000.0 in 2021, then declined by 1.44% to $890000.0 in 2022, then fell by 22.25% to $692000.0 in 2023, then soared by 384.68% to $3.4 million in 2024, then rose by 23.17% to $4.1 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $4.1 million (Q4 2025), $3.4 million (Q4 2024), and $313000.0 (Q2 2024), per Business Quant data.